Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
From the Editors
Nature Reviews Genetics 10, 1 (1 January 2009) | doi:10.1038/nrg2517
From the editors
Abstract
A common rationale for funding genetic and genomic research is that it will ultimately lead to improvements in the quality of human lives. But how can this important output be maximized? Two articles in this issue discuss different ways of accelerating progress from basic research to public health benefit.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
